120 related articles for article (PubMed ID: 35794743)
1. Long Non-coding RNA UCA1 Regulates SRPK1 Expression Through miR- 99b-3p in Ovarian Cancer.
Xu J; Zheng LH; Hong YN; Xuan C; Yan SL; Lv GL; Jiang ZG; Ding XF
Protein Pept Lett; 2022; 29(10):829-838. PubMed ID: 35794743
[TBL] [Abstract][Full Text] [Related]
2. SATB1 3'-UTR and lncRNA-UCA1 competitively bind to miR-495-3p and together regulate the proliferation and invasion of gastric cancer.
Sun L; Liu L; Yang J; Li H; Zhang C
J Cell Biochem; 2019 Apr; 120(4):6671-6682. PubMed ID: 30368875
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA UCA1 modulates cell proliferation and apoptosis by regulating miR-296-3p/Myc axis in acute myeloid leukemia.
Li J; Wang M; Chen X
Cell Cycle; 2020 Jun; 19(12):1454-1465. PubMed ID: 32286143
[TBL] [Abstract][Full Text] [Related]
4. The miRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling
Dai T; Liang J; Liu W; Zou Y; Niu F; Li M; Zhang H; Li C; Fan M; Cui G
Bioengineered; 2021 Dec; 12(2):10771-10781. PubMed ID: 34793263
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA UCA1 promotes the progression of paclitaxel resistance in ovarian cancer by regulating the miR-654-5p/SIK2 axis.
Li ZY; Wang XL; Dang Y; Zhu XZ; Zhang YH; Cai BX; Zheng L
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):591-603. PubMed ID: 32016960
[TBL] [Abstract][Full Text] [Related]
6. The lncRNA 'UCA1' modulates the response to chemotherapy of ovarian cancer through direct binding to miR-27a-5p and control of UBE2N levels.
Wambecke A; Ahmad M; Morice PM; Lambert B; Weiswald LB; Vernon M; Vigneron N; Abeilard E; Brotin E; Figeac M; Gauduchon P; Poulain L; Denoyelle C; Meryet-Figuiere M
Mol Oncol; 2021 Dec; 15(12):3659-3678. PubMed ID: 34160887
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis.
Liu QY; Jiang XX; Tian HN; Guo HL; Guo H; Guo Y
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7266-7275. PubMed ID: 32706064
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
Yang X; Xin N; Qu HJ; Wei L; Han Z
Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
[TBL] [Abstract][Full Text] [Related]
9. MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer.
Xu H; Mao HL; Zhao XR; Li Y; Liu PS
J Ovarian Res; 2020 Mar; 13(1):31. PubMed ID: 32192508
[TBL] [Abstract][Full Text] [Related]
10. DLEU1 contributes to ovarian carcinoma tumourigenesis and development by interacting with miR-490-3p and altering CDK1 expression.
Wang LL; Sun KX; Wu DD; Xiu YL; Chen X; Chen S; Zong ZH; Sang XB; Liu Y; Zhao Y
J Cell Mol Med; 2017 Nov; 21(11):3055-3065. PubMed ID: 28598010
[TBL] [Abstract][Full Text] [Related]
11. lncRNA UCA1 induces autophagic gene expression via epigenetic regulation mediated by ATG16L1 and miR-132-3p in SH-SY5Y cells treated with retinoic acid.
Wen F; Zhan Q; Zou T; Tan ZG; Xiang J
Epileptic Disord; 2022 Oct; 24(5):917-927. PubMed ID: 36117315
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA.
Wang W; Hu W; Wang Y; An Y; Song L; Shang P; Yue Z
Mol Cancer; 2020 Jan; 19(1):18. PubMed ID: 31996265
[TBL] [Abstract][Full Text] [Related]
13. LncRNA UCA1 Promotes Mitochondrial Function of Bladder Cancer via the MiR-195/ARL2 Signaling Pathway.
Li HJ; Sun XM; Li ZK; Yin QW; Pang H; Pan JJ; Li X; Chen W
Cell Physiol Biochem; 2017; 43(6):2548-2561. PubMed ID: 29130995
[TBL] [Abstract][Full Text] [Related]
14. Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer.
Ha JH; Radhakrishnan R; Nadhan R; Gomathinayagam R; Jayaraman M; Yan M; Kashyap S; Fung KM; Xu C; Bhattacharya R; Mukherjee P; Isidoro C; Song YS; Dhanasekaran DN
Cancer Lett; 2024 Jun; 591():216891. PubMed ID: 38642607
[TBL] [Abstract][Full Text] [Related]
15. LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p.
Nie W; Ge HJ; Yang XQ; Sun X; Huang H; Tao X; Chen WS; Li B
Cancer Lett; 2016 Feb; 371(1):99-106. PubMed ID: 26655272
[TBL] [Abstract][Full Text] [Related]
16. Coexpression of UCA1 and ITGA2 in pancreatic cancer cells target the expression of miR-107 through focal adhesion pathway.
Gong J; Lu X; Xu J; Xiong W; Zhang H; Yu X
J Cell Physiol; 2019 Aug; 234(8):12884-12896. PubMed ID: 30569514
[TBL] [Abstract][Full Text] [Related]
17. The LINC00922 aggravates ovarian cancer progression via sponging miR-361-3p.
Wang L; Ren C; Xu Y; Yang L; Chen Y; Zhu Y
J Ovarian Res; 2021 Jun; 14(1):77. PubMed ID: 34116704
[TBL] [Abstract][Full Text] [Related]
18. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
19. UCA1 promotes cell proliferation and invasion of gastric cancer by targeting CREB1 sponging to miR-590-3p.
Gu L; Lu LS; Zhou DL; Liu ZC
Cancer Med; 2018 Apr; 7(4):1253-1263. PubMed ID: 29516678
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA UCA1 regulates proliferation and apoptosis in multiple myeloma by targeting miR-331-3p/IL6R axis for the activation of JAK2/STAT3 pathway.
Li JL; Liu XL; Guo SF; Yang Y; Zhu YL; Li JZ
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9238-9250. PubMed ID: 31773675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]